Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous TH1 T cells

Allan B Dietz, Mark R Litzow, P. A. Bulur, S. Vuk-Pavlović

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: We investigated if dendritic cells (DC), derived from patients suffering from chronic myeloid leukemia (CML) could be modified by recombinant replication-defective adenoviruses to express functional interleukin 2 (IL-2). Such modification might confer onto antigen-presenting cells the ability to stimulate expansion of effector cells. Methods: To quantify the infection efficiency of CML dendritic cells (CML-DC) by recombinant adenovirus, we measured the expression of green fluorescent protein (GFP) gene contained in the virus. In CML-DC infected with an adenovirus containing the IL-2 gene, we evaluated their ability to secrete IL-2 and stimulate proliferation of autologous T cells. Results: Uninfected CML-DC and normal DC secreted similar amounts of IL-12 and stimulated similarly efficient autologous mixed leukocyte reaction. Immature CML-DC infected by an adenovirus containing the gene for IL-2 secreted large amounts of IL-2 and stimulated proliferation of autologous T cells more efficiently than the corresponding CML-DC alone. High levels of interferon η, but not of IL-4, in cell culture supernates indicated that the proliferating cells were TH1. Infected mature CML-DC were more effective than infected immature CML-DC, showing that T cell stimulation by mature DC and by IL-2 was additive. Discussion: CML-DC can be modified genetically and functionally by recombinant replication-defective adenoviruses, providing new possibilities for clinical trials in dendritic cell-based immunotherapy.

Original languageEnglish (US)
Pages (from-to)97-105
Number of pages9
JournalCytotherapy
Volume3
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Dendritic Cells
Interleukin-2
T-Lymphocytes
Adenoviridae
Genes
Mixed Lymphocyte Culture Test
Antigen-Presenting Cells
Interleukin-12
Green Fluorescent Proteins
Interleukin-4
Immunotherapy
Interferons
Cell Culture Techniques
Clinical Trials
Viruses

ASJC Scopus subject areas

  • Immunology

Cite this

Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous TH1 T cells. / Dietz, Allan B; Litzow, Mark R; Bulur, P. A.; Vuk-Pavlović, S.

In: Cytotherapy, Vol. 3, No. 2, 2001, p. 97-105.

Research output: Contribution to journalArticle

@article{a6961cda10124543a66662d0e55a6d6c,
title = "Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous TH1 T cells",
abstract = "Background: We investigated if dendritic cells (DC), derived from patients suffering from chronic myeloid leukemia (CML) could be modified by recombinant replication-defective adenoviruses to express functional interleukin 2 (IL-2). Such modification might confer onto antigen-presenting cells the ability to stimulate expansion of effector cells. Methods: To quantify the infection efficiency of CML dendritic cells (CML-DC) by recombinant adenovirus, we measured the expression of green fluorescent protein (GFP) gene contained in the virus. In CML-DC infected with an adenovirus containing the IL-2 gene, we evaluated their ability to secrete IL-2 and stimulate proliferation of autologous T cells. Results: Uninfected CML-DC and normal DC secreted similar amounts of IL-12 and stimulated similarly efficient autologous mixed leukocyte reaction. Immature CML-DC infected by an adenovirus containing the gene for IL-2 secreted large amounts of IL-2 and stimulated proliferation of autologous T cells more efficiently than the corresponding CML-DC alone. High levels of interferon η, but not of IL-4, in cell culture supernates indicated that the proliferating cells were TH1. Infected mature CML-DC were more effective than infected immature CML-DC, showing that T cell stimulation by mature DC and by IL-2 was additive. Discussion: CML-DC can be modified genetically and functionally by recombinant replication-defective adenoviruses, providing new possibilities for clinical trials in dendritic cell-based immunotherapy.",
author = "Dietz, {Allan B} and Litzow, {Mark R} and Bulur, {P. A.} and S. Vuk-Pavlović",
year = "2001",
doi = "10.1080/14653240152584505",
language = "English (US)",
volume = "3",
pages = "97--105",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous TH1 T cells

AU - Dietz, Allan B

AU - Litzow, Mark R

AU - Bulur, P. A.

AU - Vuk-Pavlović, S.

PY - 2001

Y1 - 2001

N2 - Background: We investigated if dendritic cells (DC), derived from patients suffering from chronic myeloid leukemia (CML) could be modified by recombinant replication-defective adenoviruses to express functional interleukin 2 (IL-2). Such modification might confer onto antigen-presenting cells the ability to stimulate expansion of effector cells. Methods: To quantify the infection efficiency of CML dendritic cells (CML-DC) by recombinant adenovirus, we measured the expression of green fluorescent protein (GFP) gene contained in the virus. In CML-DC infected with an adenovirus containing the IL-2 gene, we evaluated their ability to secrete IL-2 and stimulate proliferation of autologous T cells. Results: Uninfected CML-DC and normal DC secreted similar amounts of IL-12 and stimulated similarly efficient autologous mixed leukocyte reaction. Immature CML-DC infected by an adenovirus containing the gene for IL-2 secreted large amounts of IL-2 and stimulated proliferation of autologous T cells more efficiently than the corresponding CML-DC alone. High levels of interferon η, but not of IL-4, in cell culture supernates indicated that the proliferating cells were TH1. Infected mature CML-DC were more effective than infected immature CML-DC, showing that T cell stimulation by mature DC and by IL-2 was additive. Discussion: CML-DC can be modified genetically and functionally by recombinant replication-defective adenoviruses, providing new possibilities for clinical trials in dendritic cell-based immunotherapy.

AB - Background: We investigated if dendritic cells (DC), derived from patients suffering from chronic myeloid leukemia (CML) could be modified by recombinant replication-defective adenoviruses to express functional interleukin 2 (IL-2). Such modification might confer onto antigen-presenting cells the ability to stimulate expansion of effector cells. Methods: To quantify the infection efficiency of CML dendritic cells (CML-DC) by recombinant adenovirus, we measured the expression of green fluorescent protein (GFP) gene contained in the virus. In CML-DC infected with an adenovirus containing the IL-2 gene, we evaluated their ability to secrete IL-2 and stimulate proliferation of autologous T cells. Results: Uninfected CML-DC and normal DC secreted similar amounts of IL-12 and stimulated similarly efficient autologous mixed leukocyte reaction. Immature CML-DC infected by an adenovirus containing the gene for IL-2 secreted large amounts of IL-2 and stimulated proliferation of autologous T cells more efficiently than the corresponding CML-DC alone. High levels of interferon η, but not of IL-4, in cell culture supernates indicated that the proliferating cells were TH1. Infected mature CML-DC were more effective than infected immature CML-DC, showing that T cell stimulation by mature DC and by IL-2 was additive. Discussion: CML-DC can be modified genetically and functionally by recombinant replication-defective adenoviruses, providing new possibilities for clinical trials in dendritic cell-based immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0034997855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034997855&partnerID=8YFLogxK

U2 - 10.1080/14653240152584505

DO - 10.1080/14653240152584505

M3 - Article

C2 - 12028832

AN - SCOPUS:0034997855

VL - 3

SP - 97

EP - 105

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

IS - 2

ER -